Nicotinamide Adenine Dinucleotide and Skeletal Muscle Metabolic Phenotype

Sponsor / Institution: University of Birmingham

Purpose

Assess the physiological consequences of elevating NAD+ availability using NR supplementation in skeletal muscle tissue, and examine its effect upon muscle metabolic phenotype.

Study Design

Double blind, controlled cross-over

Dose

1000mg/day

Length of Intervention

21 days

Intrinsic Capacity

Locomotion

Status

Unknown status (complete)

Condition or Disease 

Aging

Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.

Clinical Studies, LocomotionANAD Staff